You just read:

Tillotts Pharma AG Introduces the New Technology OPTICORE™ (OPTImized COlonic RElease) for Colonic Targeting of Active Molecules for the Treatment of Any Colon Disease

News provided by

Tillotts Pharma AG

18 Nov, 2016, 15:42 GMT